Advertisement
Screener

Lite Strategy, Inc. (LITS) Earnings Per Share (Basic)

2.8 / 5 stars · 68/120 Roast Me

Lite Strategy, Inc. Earnings Per Share (Basic)

Lite Strategy, Inc. (LITS) reported Earnings Per Share (Basic) of -$0.66 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasic · last filed 2026-05-13

  • Lite Strategy, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.66.
  • Lite Strategy, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.82.
  • Lite Strategy, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.12.
  • Lite Strategy, Inc. earnings per share, basic for the quarter ending 2025-03-31 was -$0.39.
  • Lite Strategy, Inc. earnings per share, basic for fiscal 2025 was -$2.39, a 189.51% decline from fiscal 2024.
  • Lite Strategy, Inc. earnings per share, basic for fiscal 2024 was $2.67.
  • Lite Strategy, Inc. earnings per share, basic for fiscal 2023 was -$4.78.
  • Lite Strategy, Inc. earnings per share, basic for fiscal 2022 was -$8.75.
Period endEarnings Per Share, Basic 3 monthEarnings Per Share, Basic 3 month as first filedEarnings Per Share, Basic 6 monthEarnings Per Share, Basic 6 month as first filedEarnings Per Share, Basic 9 monthEarnings Per Share, Basic 9 month as first filedEarnings Per Share, Basic 12 monthEarnings Per Share, Basic 12 month as first filed
2026-03-31-$0.66
10-Q · filed 2026-05-13
-$1.68
10-Q · filed 2026-05-13
2025-12-31-$0.82
10-Q · filed 2026-02-17
-$1.03
10-Q · filed 2026-02-17
2025-09-30-$0.12
10-Q · filed 2025-11-14
2025-06-30-$2.39
10-K · filed 2025-09-26
2025-03-31-$0.39
10-Q · filed 2026-05-13
-$1.99
10-Q · filed 2026-05-13
2024-12-31-$0.40
10-Q · filed 2026-02-17
-$1.60
10-Q · filed 2026-02-17
2024-09-30-$1.20
10-Q · filed 2025-11-14
2024-06-30$2.67
10-K · filed 2025-09-26
2024-03-31-$1.37
10-Q · filed 2025-05-13
$5.43
10-Q · filed 2025-05-13
2023-12-31-$1.66
10-Q · filed 2025-02-12
$6.80
10-Q · filed 2025-02-12
2023-09-30$8.46
10-Q · filed 2024-11-12
2023-06-30-$1.51
derived: net income ÷ weighted average shares · filed 2024-09-19
-$3.82
derived: net income ÷ weighted average shares · filed 2024-09-19
-$2.28
derived: net income ÷ weighted average shares · filed 2024-09-19
-$4.78
10-K · filed 2024-09-19
2023-03-31-$2.32
10-Q · filed 2024-05-09
-$0.78
derived: net income ÷ weighted average shares · filed 2024-05-09
-$3.27
10-Q · filed 2024-05-09
-$5.69
derived: net income ÷ weighted average shares · filed 2024-05-09
2022-12-31$1.54
10-Q · filed 2024-02-13
$0.08
10-Q · filed 2023-02-09
-$0.96
10-Q · filed 2024-02-13
-$0.05
10-Q · filed 2023-02-09
-$3.37
derived: net income ÷ weighted average shares · filed 2024-02-13
-$4.68
derived: net income ÷ weighted average shares · filed 2024-02-13
2022-09-30-$2.49
10-Q · filed 2023-11-09
-$0.12
10-Q · filed 2022-11-14
-$4.91
derived: net income ÷ weighted average shares · filed 2023-11-09
-$6.22
derived: net income ÷ weighted average shares · filed 2023-11-09
-$1.46
derived: net income ÷ weighted average shares · filed 2023-11-09
2022-06-30-$2.41
derived: net income ÷ weighted average shares · filed 2023-09-26
-$3.72
derived: net income ÷ weighted average shares · filed 2023-09-26
-$0.79
derived: net income ÷ weighted average shares · filed 2023-09-26
-$8.75
10-K · filed 2023-09-26
-$0.44
10-K · filed 2022-09-08
2022-03-31-$1.31
10-Q · filed 2023-05-11
-$0.07
10-Q · filed 2022-05-23
-$0.31
derived: net income ÷ weighted average shares · filed 2023-05-11
-$6.31
10-Q · filed 2023-05-11
-$0.32
10-Q · filed 2022-05-23
-$0.52
derived: net income ÷ weighted average shares · filed 2023-05-11
2021-12-31-$0.10
10-Q · filed 2023-02-09
-$0.05
10-Q · filed 2022-02-10
-$0.26
10-Q · filed 2023-02-09
-$0.15
10-Q · filed 2022-02-10
-$0.32
derived: net income ÷ weighted average shares · filed 2023-02-09
-$0.55
derived: net income ÷ weighted average shares · filed 2023-02-09
2021-09-30-$0.16
10-Q · filed 2022-11-14
-$0.11
10-Q · filed 2021-11-10
-$0.23
derived: net income ÷ weighted average shares · filed 2022-11-14
-$0.46
derived: net income ÷ weighted average shares · filed 2022-11-14
-$0.53
derived: net income ÷ weighted average shares · filed 2022-11-14
2021-06-30-$0.07
derived: net income ÷ weighted average shares · filed 2022-09-08
-$0.30
derived: net income ÷ weighted average shares · filed 2022-09-08
-$0.37
derived: net income ÷ weighted average shares · filed 2022-09-08
-$0.37
10-K · filed 2022-09-08
-$0.45
10-K · filed 2021-09-02
2021-03-31-$0.23
10-Q · filed 2022-05-23
-$0.28
10-Q · filed 2021-05-06
-$0.30
derived: net income ÷ weighted average shares · filed 2022-05-23
-$0.29
10-Q · filed 2022-05-23
-$0.40
10-Q · filed 2021-05-06
-$0.47
derived: net income ÷ weighted average shares · filed 2022-09-08
2020-12-31-$0.07
10-Q/A · filed 2022-05-23
-$0.10
10-Q · filed 2021-02-04
-$0.07
10-Q/A · filed 2022-05-23
-$0.12
10-Q · filed 2021-02-04
-$0.24
derived: net income ÷ weighted average shares · filed 2022-09-08
-$0.29
derived: net income ÷ weighted average shares · filed 2022-09-08
2020-09-30$0.01
10-Q/A · filed 2022-05-23
-$0.02
10-Q · filed 2020-11-10
-$0.17
derived: net income ÷ weighted average shares · filed 2022-09-08
-$0.21
derived: net income ÷ weighted average shares · filed 2022-09-08
-$0.43
derived: net income ÷ weighted average shares · filed 2022-09-08
2020-06-30-$0.17
10-K · filed 2020-09-09
-$0.23
derived: net income ÷ weighted average shares · filed 2022-09-08
-$0.46
derived: net income ÷ weighted average shares · filed 2022-09-08
-$0.52
10-K · filed 2022-09-08
-$0.51
10-K · filed 2020-09-09
2020-03-31-$0.04
10-Q · filed 2021-05-06
-$0.27
derived: net income ÷ weighted average shares · filed 2021-05-06
-$0.32
10-Q · filed 2021-05-06
-$0.30
derived: net income ÷ weighted average shares · filed 2022-05-23
2019-12-31-$0.26
10-Q · filed 2021-02-04
-$0.30
10-Q · filed 2021-02-04
-$0.27
derived: net income ÷ weighted average shares · filed 2022-05-23
-$0.51
derived: net income ÷ weighted average shares · filed 2022-05-23
2019-09-30-$0.04
10-Q · filed 2020-11-10
$0.00
derived: net income ÷ weighted average shares · filed 2022-05-23
-$0.24
derived: net income ÷ weighted average shares · filed 2022-05-23
-$0.07
derived: net income ÷ weighted average shares · filed 2022-05-23
2019-06-30$0.04
10-K · filed 2020-09-09
-$0.20
derived: net income ÷ weighted average shares · filed 2022-05-23
-$0.03
derived: net income ÷ weighted average shares · filed 2022-05-23
-$0.24
10-K/A · filed 2022-05-23
2019-03-31-$0.24
10-K · filed 2020-09-09
-$0.07
derived: net income ÷ weighted average shares · filed 2020-05-07
-$0.28
10-Q · filed 2020-05-07
2018-12-31$0.17
10-K · filed 2020-09-09
-$0.04
10-Q · filed 2020-02-06
2018-09-30-$0.21
10-K · filed 2020-09-09
2018-06-30-$0.36
10-K · filed 2019-08-28
-$0.55
derived: net income ÷ weighted average shares · filed 2020-09-09
-$0.73
derived: net income ÷ weighted average shares · filed 2020-09-09
-$0.97
10-K · filed 2020-09-09
2018-03-31-$0.16
10-K · filed 2019-08-28
-$0.32
derived: net income ÷ weighted average shares · filed 2019-05-09
-$0.56
10-Q · filed 2019-05-09
2017-12-31-$0.16
10-K · filed 2019-08-28
-$0.40
10-Q · filed 2019-02-07
2017-09-30-$0.24
10-K · filed 2019-08-28
2017-06-30-$0.12
10-K · filed 2018-08-30
$0.07
10-K · filed 2019-08-28
2017-03-31-$0.02
10-K · filed 2018-08-30
$0.19
10-Q · filed 2018-05-09
2016-12-31$0.32
10-K · filed 2018-08-30
$0.21
10-Q · filed 2018-02-08
2016-09-30-$0.12
10-K · filed 2018-08-30
2016-06-30-$0.17
10-K · filed 2017-09-05
-$0.61
10-K · filed 2018-08-30
2016-03-31-$0.16
10-K · filed 2017-09-05
-$0.44
10-Q · filed 2017-05-04
2015-12-31-$0.15
10-K · filed 2017-09-05
-$0.28
10-Q · filed 2017-02-08
2015-09-30-$0.13
10-K · filed 2017-09-05
2015-06-30-$1.16
10-K · filed 2017-09-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
Xilio Therapeutics, Inc. (XLO)United States$0.052B
PDS Biotechnology Corp (PDSB)United States$0.045B
SCYNEXIS INC (SCYX)United States$0.045B
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Clene Inc. (CLNN)United States$0.054B-1.99
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38